Sterling Capital Management LLC Lexicon Pharmaceuticals, Inc. Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
A detailed history of Sterling Capital Management LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 272 shares of LXRX stock, worth $296. This represents 0.0% of its overall portfolio holdings.
Number of Shares
272Holding current value
$296% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LXRX
# of Institutions
137Shares Held
242MCall Options Held
617KPut Options Held
286K-
Artal Group S.A. Luxembourg, N4136MShares$148 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$42.4 Million3.05% of portfolio
-
Orbimed Advisors LLC San Diego, CA11MShares$12 Million0.41% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$10.8 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.29MShares$9.04 Million0.44% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $206M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...